Burning Rock Biotech Limited BNR Publishes 2022 Annual Report on Form 20-F (9856W)
April 21 2023 - 2:00AM
UK Regulatory
TIDMBNR
RNS Number : 9856W
Burning Rock Biotech Limited
21 April 2023
B urning R ock Publishes 2022 Annual Report on Form 20-F
GUANGZHOU, China, April 21, 2023-Burning Rock Biotech Limited
(NASDAQ: BNR and LSE: BNR , the "Company" or "Burning Rock"), a
company focused on the application of next generation sequencing
technology in the field of precision oncology, announces that on
April 20, 2023 it filed its Annual Report on Form 20-F for the year
ended December 31, 2022 (the "Form 20-F") with the U.S. Securities
and Exchange Commission ("SEC"). The Form 20-F is available for
viewing on the SEC website at www.sec.gov and also on the Company's
website at http://ir.brbiotech.com . The Form 20-F has also been
submitted to the National Storage Mechanism and will shortly be
available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
About Burning Rock
Burning Rock Biotech Limited (NASDAQ: BNR; LSE: BNR), whose
mission is to guard life via science, focuses on the application of
next generation sequencing (NGS) technology in the field of
precision oncology. Its business consists of i) NGS-based therapy
selection testing for late-stage cancer patients, and ii) cancer
early detection, which has moved beyond proof-of-concept R&D
into the clinical validation stage.
For more information about Burning Rock, please visit:
http://ir.brbiotech.com .
Safe Harbor Statement
This press release contains forward-looking statements. These
statements constitute "forward-looking" statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended, and as defined in the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be
identified by terminology such as "will," "expects," "anticipates,"
"future," "intends," "plans," "believes," "estimates," "target,"
"confident" and similar statements. Burning Rock may also make
written or oral forward-looking statements in its periodic reports
to the SEC, in its annual report to shareholders, in press releases
and other written materials and in oral statements made by its
officers, directors or employees to third parties. Statements that
are not historical facts, including statements about Burning Rock's
beliefs and expectations, are forward-looking statements. Such
statements are based upon management's current expectations and
current market and operating conditions, and relate to events that
involve known or unknown risks, uncertainties and other factors,
all of which are difficult to predict and many of which are beyond
Burning Rock's control. Forward-looking statements involve risks,
uncertainties and other factors that could cause actual results to
differ materially from those contained in any such statements. All
information provided in this press release is as of the date of
this press release, and Burning Rock does not undertake any
obligation to update any forward-looking statement as a result of
new information, future events or otherwise, except as required
under applicable law.
Contact: IR@brbiotech.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACSDXGDSBDDDGXG
(END) Dow Jones Newswires
April 21, 2023 02:00 ET (06:00 GMT)
Burning Rock Biotech (LSE:BNR)
Historical Stock Chart
From Apr 2024 to May 2024
Burning Rock Biotech (LSE:BNR)
Historical Stock Chart
From May 2023 to May 2024